SGRY stock sentiment todaySurgery Partners, Inc.

Surgery Partners is navigating a complex transition, balancing strategic asset sales to deleverage against temporary earnings volatility and high interest costs.

Full model breakdown (analyst / gossip / momentum weights) is a Pro feature. Modelled for SGRY. Not financial advice.

The market narrative is polarized between value investors seeing a 'deep value' play and momentum traders wary of the recent sell-off. The sale of Idaho Falls Community Hospital is the primary talking point, viewed as a necessary move for the balance sheet but one that complicates short-term earnings visibility.

• ·Potential undervaluation after recent price drops
• ·Strategic divestitures to address debt load
• ·Strong Q2 earnings beat countered by future guidance uncertainty
• ·Speculation regarding private equity interest or M&A activity

SGRY shows robust top-line growth and strong same-facility revenue trends, but the bottom line remains pressured by a high debt-to-equity ratio and significant interest expense. While EBITDA margins are healthy for the sector, free cash flow generation is prioritized for debt reduction rather than expansion.

• ·High Net Debt/EBITDA ratio (approx 3.5x-4.0x)
• ·Strong Same-Facility Revenue growth (~9-10%)
• ·Consistent double-digit Revenue growth (YoY)
• ·Negative or thin GAAP Net Income due to high interest expense

Whose money is actually in the stock — insider open-market trades and the patience of the institutional holder base.

Mixed conviction — no decisive signal from insiders or the holder base.

• ·Insiders bought a net $144K on the open market in the last 120 days.

Source: SEC EDGAR Form 4 + 13F holder register. Option exercises, grants, gifts and tax withholding are excluded — only open-market purchases and sales count. Not financial advice.

• ·High sensitivity to interest rate environments
• ·Execution risk in re-deploying capital from asset sales
• ·Labor cost inflation in the healthcare sector
• ·Concentration risk in specific surgical specialties

How direct competitors stack up against SGRY right now.

• HOT
  THCTenet Healthcare

  HOTTER — trading at a more attractive EV/EBITDA multiple while generating significantly higher free cash flow from its massive USPI ambulatory segment.

  See full analysis →
• HOT
  HCAHCA Healthcare

  HOTTER — offers superior scale and a more defensive diversified moat with consistent share buybacks that SGRY cannot currently afford.

  See full analysis →
• NEUTRAL
  ENSGThe Ensign Group

  SIDEWAYS — while in skilled nursing, they share the facility-based model but currently command a premium valuation that limits near-term upside compared to SGRY's recovery potential.

  See full analysis →

Consensus average of 10 analysts · median 19.00

Source: StockAnalysis.com · updated 2026-08-28

• Yahoo Finance
  Surgery Partners (SGRY) Stock May Be Undervalued After Q2 Earnings Beat
• GuruFocus
  Surgery Partners Inc (SGRY) Stock Down 4.2% -- Now Undervalued? GF Score: 61/100
• Finviz
  SGRY
• Value Research
  Surgery Partners Inc. (SGRY) Shareholding Pattern – Promoters, FIIs & DIIs
• simplywall.st
  Surgery Partners (SGRY) Stock Drops As Idaho Falls Sale Reshapes Debt Story
• Quiver Quantitative
  Surgery Partners Inc. (SGRY) Stock Falls on Q4 2025 Earnings